Cyberport Venture Capital Forum (CVCF) 2025 Returns Under the Theme "The Innovation–Venture Nexus: Igniting Transformative Success"
Updated
January 8, 2026 6:34 PM
As the venture capital world recalibrates amid global uncertainty, Cyberport Venture Capital Forum (CVCF) 2025 returns on November 6-7 under the theme “The Innovation–Venture Nexus: Igniting Transformative Success”. PHOTO: CYBERPORT
The two-day forum will once again bring together global and local leaders to explore how technology, capital and collaboration intersect to drive the next wave of growth. Entrepreneurs, investors and innovators will exchange insights on artificial intelligence, digital assets and Web 3.0—technologies that are reshaping industries and redefining both risk and opportunity.
As industries face challenges from geopolitical shifts, regulatory changes and market volatility, CVCF will serve as a platform to address a defining question: How can innovation remain bold and visionary in an ever-evolving funding landscape? Through keynotes, panel discussions and interactive sessions, the forum will spotlight the transformative potential of technologies like artificial intelligence (AI), Web 3.0 and digital assets while offering practical strategies to turn disruption into market advantage.
With investor matching, power pitches, start-up clinics and workshops, CVCF 2025 offers a front-row seat to emerging markets across Asia, the Middle East, the United States and Europe, connecting forward-thinking investors with visionary entrepreneurs. It is not just a conference—it’s a bridge between ideas and investment designed to ignite breakthroughs and foster growth in the global innovation ecosystem. It provides a unique platform for startups and investors to navigate the complexities of today’s economy while seizing new opportunities for collaboration and growth.
To preview the conversations ahead, three speakers share perspectives on trends shaping the future of innovation, investment and entrepreneurship, setting the stage for the discussions that will unfold at CVCF 2025.
Co-founder and CEO, AIFT
Session: Riding the Middle East Momentum — Capitalizing Unique Innovation and Investment Strengths
As the Middle East accelerates its shift from oil dependence toward digital diversification, the region is becoming a focal point for blockchain and AI investment. In his upcoming session, Alvin Kwock will explore the region’s innovation potential — and here, he shares some of his views on the opportunities shaping that transformation.
Alvin Kwock, co-founder and CEO of AIFT, oversees operations across three verticals: AI and cybersecurity (Vulcan and Cymetrics), blockchain (OneInfinity and OneSavie) and pet and B2C (OneDegree). With local operations spanning Asia and the Middle East, AIFT is expanding rapidly.
When asked about the Middle East’s rapid rise as a global innovation hub, Kwock said that the region is shifting from a petroleum-dependent economy to one increasingly diversified through technology and innovation, with markets advancing blockchain and AI technologies. AIFT is prioritizing expansion in the UAE and Saudi Arabia, where AI investment and regulatory openness create immense potential. Hong Kong’s expertise in financial risk management acts as a “confidence anchor” for international markets, allowing AIFT to deliver compliant solutions tailored for emerging markets while developing Sharia-compliant, regulation-aligned technologies.
“Hong Kong’s storied expertise in financial risk management acts as a ‘confidence anchor’ for international markets.”
He also noted that the region’s accelerating digital adoption opens unique opportunities for AI, insurtech and fintech. The UAE and Bahrain’ embrace of virtual assets, combined with Hong Kong’s proven frameworks, provide a foundation for localized solutions. By integrating risk oversight and regulatory best practices, AIFT supports stable market growth and delivers specialized insurance to enhance resilience in emerging markets.
On managing geopolitical risk, Kwock explained that AIFT mitigates exposure through local partnerships, regulatory alignment and cultural understanding. By hiring Arab employees and ensuring operations align with Islamic values, AIFT strengthens Hong Kong–Middle East collaboration. This approach, he said, offers a blueprint for startups: prioritize local engagement and flexibility to balance risk and growth.
Founder, Hash Global Advisory Company Ltd.
Session: From Hype to Holdings — Where Smart Money Goes in Digital Assets 2025–2027
With institutional frameworks for Web 3.0 maturing, investors are increasingly focused on sustainable value creation. In his session, Kang Shen will discuss how smart capital is moving beyond speculation toward real-world utility—themes echoed in his reflections shared ahead of the forum.
Kang Shen, founder of Hash Global Advisory, applies value-investing principles to the Web 3.0 sector. A graduate of Fudan University and the University of Chicago Booth School of Business and a Chartered Financial Analyst (CFA), Shen has more than 20 years of financial industry experience with roles at the Industrial Bank of Japan, PIMCO and Bosera Asset Management.
On the tokenization of real-world assets, Shen observed that the RWA sector remains in its early phase of regulatory and infrastructure development. Over the next two years, as compliance systems mature, scalable projects with tangible value will emerge. For now, his approach remains cautious, focusing on fundamentals rather than inflated market narratives.
He also shared his optimism for three areas with the most potential upside: Web 3.0 Culture and Entertainment—including projects like Meet48 and Offgrid; Web 3.0 E-Commerce and Payments—with ventures such as WSPN, RD Technologies and Bitgoods; and On-Chain Data and Data Assets—such as Chainbase and Data Dance Chain. These, he noted, represent meaningful real-world applications of Web 3.0 technologies.
“Web 3.0 is currently undergoing a process of value realignment.”
Shen emphasized that Hash Global has always been committed to applying value-investing principles to the field of digital asset management. As early as 2019, the firm proposed using a monetary equation framework to evaluate ecosystem tokens and recently defined a new class—“Value-Functional Tokens”. He believes Web 3.0 is now undergoing a process of value realignment, where genuine utility will determine long-term worth.
Founder and CEO, Zhejiang Linctex Digital Technology Co., Ltd. (Style3D)
Session: Strategic Exits — IPO Paths for Expanding Rapid-Growth Companies
The fashion and textile industry is undergoing rapid digital transformation. Against this backdrop, Eric Liu will join CVCF 2025 to discuss strategic growth and expansion paths for fast-scaling companies.
Eric Liu, founder and CEO of Zhejiang Linctex Digital Technology Co., Ltd. (Style3D), holds dual master’s degrees in applied computing and molecular biology from VUB University in Belgium and a PhD in Electronic Information Engineering from Zhejiang University. A serial entrepreneur in the textile industry, Liu founded Style3D to drive digital transformation through AI and 3D technology.
He explained that Style3D’s fusion of AI and 3D technology builds a full-chain digital ecosystem. AI-driven design tools powered by large language models shorten design cycles from weeks to hours, while 3D simulation reduces prototyping costs by 30 percent. The company’s self-developed simulation engine supports virtual fashion shows and sustainability initiatives by optimizing fabric usage.
“Style3D’s fusion of AI and 3D technology builds a full-chain digital ecosystem.”
On the company’s origins, Liu said that traditional fashion R&D cycles are slow and costly. By integrating AI for pattern generation and 3D for design-to-production links, Style3D overcomes these barriers. With over 200 core patents and an extensive database of 2.3 million fabric properties and 1.2 million garment templates, the company leads digital fashion innovation.
Looking ahead, Liu noted that Style3D reinvests 40 percent of annual revenue into R&D, develops AI-driven trend prediction tools and expands innovation hubs in Paris and Milan. By leading the standardization of “3D Digital Fashion Infrastructure”, Style3D is setting the industry benchmark for the next era of intelligent manufacturing.
As global innovators prepare to gather at CVCF 2025, the forum promises to ignite ideas, discoveries and partnerships that will shape the future of technology and investment. From cutting-edge insights to practical strategies, the conversations starting here are just the beginning of a journey to redefine what’s possible in the global innovation ecosystem.
.jpg)
Keep Reading
The Canberra biotech startup is helping processors detect spoilage risks before milk reaches the shelf.
Updated
August 13, 2026 1:01 AM
CYBERTONGUE® Food Testing System, developed by PPB Technology. IMAGE: PPB Technology
Anyone who has opened a carton of milk before its expiry date only to find that it smells off or tastes bitter has experienced the problem firsthand. For dairy processors, the same issue can play out across thousands of litres. Milk may pass routine quality checks, make it through production and still spoil before reaching the end of its expected shelf life.
CYBERTONGUE®, a biosensing platform, is designed to give dairy processors an earlier warning.
Developed by Canberra-based biotech startup PPB Technology, the compact food testing system allows processors to analyse milk on-site and receive results within minutes. Its first commercial application detects protease, an enzyme linked to spoilage, shorter shelf life and production losses across dairy products.
Dairy companies already test milk for fat, protein, bacteria, antibiotics and other indicators. Samples from individual farms may be sent to central laboratories, while tanker loads are tested again when they reach processing plants. These checks provide useful information, but they do not always show whether milk will remain stable in a UHT carton, meet a supermarket’s shelf-life requirements or produce the expected amount of cheese.
Even after heat treatment, protease can continue affecting milk. For processors making UHT milk, fresh milk or mature cheese, that creates a costly blind spot.
“Right now, dairy processors are working blind on this,” PPB Technology founder Stephen Trowell told Ventureport. “It’s becoming more of a problem as customers expect longer shelf lives and higher quality.”
CYBERTONGUE® uses engineered biosensing proteins that emit blue and green light. The balance between the two colours changes when the protein reacts with a target substance. The reader measures that shift and calculates how much of the target is present.
Trowell describes himself as a protein engineer at heart. He spent around three decades at CSIRO, Australia's national science and technology agency, and close to four decades in research before becoming a startup founder. The technology behind CYBERTONGUE® grew out of years of biological research, including earlier experiments involving wine aromas and explosives detection.
PPB initially developed its technology to measure plasmin, an enzyme derived from cows. After feedback from the dairy industry, the company shifted its focus to bacterial proteases, which were identified as a more pressing spoilage problem. The platform can make some existing tests faster, but PPB chose to focus first on a measurement previously unavailable to processors.
“Where we’ve chosen to lead is with a measurement nobody else can do at all,” he said. “The blue ocean, if you like.”
That focused entry point shapes PPB’s wider strategy. CYBERTONGUE® could eventually test for lactose, allergens, microbial toxins and other targets. Yet launching everything at once would stretch a six-person company too far. Protease gives it a clear route into dairy, where the financial value is easier to demonstrate.
A processor that detects high protease activity may redirect a batch of milk away from long-life products and use it for yoghurt, curd or another product where the enzyme causes less damage. PPB also says its tests can help trace problems in the milk supply and detect biofilms on processing equipment, allowing factories to take corrective cleaning measures.
Fresh milk presents another sizeable opportunity, with the global market estimated at around US$81 billion in 2026 and projected to grow at 6.83% annually through 2035. At that scale, even small gains in shelf-life consistency could prevent substantial losses. Supermarkets often require milk to have a minimum amount of shelf life remaining on delivery. Products that fall short may be rejected, discounted or discarded at the processor’s expense. While Australian processors typically aim for a shelf life of 19 to 21 days, they do not always achieve it. CYBERTONGUE® could help them reach that target more consistently.
Cheese producers face a related issue. Protease can create bitter flavours in hard cheeses and reduce production yield. Cheesemakers add another enzyme, chymosin, during production, often without knowing how much protease activity is already present in the milk. Better information could help them adjust the process and get more value from the same raw material.
PPB sells the reader as laboratory equipment, but its long-term business model centres on repeat testing. Customers buy the machine, then purchase a PPB reagent cartridge each time they run an assay. Future tests are intended to work on the same reader, making the system more useful as the catalogue expands.
CYBERTONGUE®’s compact design reflects PPB’s focus on practical onsite testing. The device is small enough to fit into two cupped hands and comes with a tablet running PPB’s software.
At the time of the interview, 13 to 15 systems had been installed with paying customers. PPB had made sales in 11 countries across five continents, with Europe as its largest market.
Trowell describes PPB as “born global”. While Australia and New Zealand have sophisticated dairy industries, Trowell thinks CYBERTONGUE® may offer even more value in regions where milk quality is less consistent, transport routes are longer or refrigeration is harder to maintain.
Trowell also believes PPB has a strong competitive moat, with the combination of manufacturing both the hardware and consumable reagents. Patents form one layer, but he does not consider legal protection sufficient on its own. A competitor would need expertise in protein engineering, reagent production, optical hardware, software and dairy processing.
Calibration adds another barrier. For each new box of reagents, PPB securely uploads the required calibration data to the customer’s machine. A third party could not simply manufacture a cartridge with the same dimensions and expect it to work correctly.
“We own the whole stack,” Trowell said, referring to everything from the sensing molecule to the hardware, software and cloud platform.
That said, he accepts that no technology is impossible to copy. His view is that PPB’s mix of scientific knowledge, integrated system and experience in dairy gives it enough of a head start to build a meaningful position before competitors catch up.
The technology could eventually reach beyond food. Trowell sees possible uses in environmental testing, veterinary care and medical diagnostics, including the analysis of blood, serum or saliva. PPB has already discussed potential applications with organisations outside the food industry.
For now, however, moving directly into clinical diagnostics would create more risk than opportunity. Medical products can require years of trials, extensive regulatory work and large development budgets. PPB would also need to build new sales channels and choose between many possible clinical uses without knowing which one would attract the strongest demand.
For these reasons, food testing offers PPB a clearer path. The regulatory barriers are generally lower, customers have immediate operational problems, and PPB has already built relationships in dairy. Once the platform has proved itself commercially, the company could enter other sectors through partnerships or licensing.
Trowell has held that view for years. The immediate goal is to build a successful food testing company rather than chase the prestige often attached to medical biotechnology.
The opportunity may also expand as food production becomes more complex. Dairy factories increasingly process oat, soy and other alternatives on equipment that also handles cow’s milk. This creates cross-contamination and allergen risks, offering another potential use for CYBERTONGUE®.
PPB still has plenty to prove. It must secure repeat reagent orders, convert early trials into wider deployments and expand its test catalogue without compromising accuracy. Scaling an integrated biotech hardware business across international markets will not be simple.
Still, its approach offers a useful lesson for other deep-tech startups. Instead of beginning with every possible application, PPB picked a specific problem that costs customers money today. It built a product around that pain point, then used the same technology as the foundation for a broader platform.
As Trowell put it, customers “need it fast, and they need it right.” CYBERTONGUE® is betting that food testing can deliver both.